ALLERGAN’s OCUFEN POST-OP CYSTOID MACULAR EDEMA DATA NEEDS MORE ANALYSIS OF DROPOUTS BEFORE APPROVAL, FDA OPHTHALMIC DRUGS SUBCOMMITTEE CONCLUDES OCT. 27

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".